Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,919 | 0.0% | 28,911 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 246 | 0.0% | 7,128 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 4,862 | 0.0% | 307,745 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 3,687 | 0.0% | 289,376 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 7,863 | 0.0% | 418,246 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 5,565 | 0.0% | 287,282 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 2,674 | 0.0% | 102,896 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 10,281 | 0.0% | 359,470 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 2,564 | 0.0% | 83,793 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 8,863 | 0.0% | 329,838 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 12,146 | 0.0% | 340,618 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 11,270 | 0.0% | 443,684 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 3,414 | 0.0% | 84,165 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 6,771 | 0.0% | 204,866 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,848 | 0.0% | 137,683 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 9,157 | 0.0% | 199,118 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 8,647 | 0.0% | 130,419 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 11,081 | 0.0% | 177,492 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 13,452 | 0.0% | 162,432 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 12,695 | 0.0% | 191,448 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 21,069 | 0.0% | 274,586 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 13,615 | 0.0% | 316,184 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 19,310 | 0.0% | 447,098 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 12,976 | 0.0% | 451,010 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 19,542 | 0.0% | 308,082 | 12/31/2019 |